Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04141 (
granulocyte-macrophage colony-stimulating factor
)
6,790
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neutrophils have a very short half-life in the circulation, undergoing rapid death by apoptosis, but a number of agents can either delay or accelerate the rate at which these cells undergo death. TNFalpha can exert opposing, concentration-dependent effects on neutrophils to either accelerate their apoptosis or enhance their survival. We show that TNFalpha greatly increases the rate of turnover of
Mcl-1
, an antiapoptotic protein that plays a key role in neutrophil survival. In contrast to
Mcl-1
turnover in control- or
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
)-treated neutrophils that occurs via the proteasome, TNFalpha-accelerated
Mcl-1
turnover occurs via activation of caspases.
Mcl-1
-depleted cells thus have accelerated rates of apoptosis. While TNFalpha had no effect on
MCL-1
transcription, it induced expression of another antiapoptotic molecule, BFL-1. Low concentrations of TNFalpha (<or=1 ng/mL) stimulated BFL-1 expression, whereas higher concentrations (>or=10 ng/mL) triggered caspase-dependent acceleration of
Mcl-1
turnover. These opposing effects on 2 separate antiapoptotic systems of neutrophils explain the divergent effects of TNFalpha on neutrophil apoptosis and have important implications for understanding how TNFalpha may affect immune function in inflammatory diseases.
...
PMID:The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1. 1794 58
We studied the role of c-Jun N-terminal kinase (JNK) in human neutrophils stimulated by tumor necrosis factor-alpha (TNF-alpha) and
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
). Stimulation of neutrophils with TNF-alpha and
GM-CSF
caused phosphorylation of p54 or p46 JNK or both. The phosphorylated p46 JNK band in TNF-alpha-stimulated neutrophils mobilized faster than that in
GM-CSF
-stimulated cells. The JNK isoform transcripts expressed in neutrophils were JNK1beta1, JNK1beta2, JNK2alpha1, and JNK2alpha2. The JNK isoforms phosphorylated by TNF-alpha and
GM-CSF
stimulation were found to be JNK1 and JNK2, respectively, on the basis of the molecular mass and the capture assay. TNF-alpha-induced JNK phosphorylation was sustained in the presence of cycloheximide, which was accompanied by accelerated neutrophil apoptosis. The JNK inhibitors (SP600125 and TAT-TI-JIP(153163)) suppressed neutrophil apoptosis induced by TNF-alpha plus cycloheximide, whereas they attenuated the
GM-CSF
-mediated antiapoptotic effect on neutrophils. The JNK inhibitor did not affect the levels of
Mcl-1
and XIAP (antiapoptotic molecules), which were regulated by TNF-alpha plus cycloheximide and
GM-CSF
. The JNK inhibitor markedly suppressed TNF-alpha-induced and
GM-CSF
-induced superoxide release. These findings suggest that JNK1 and JNK2 are involved in TNF-alpha-induced neutrophil apoptosis and
GM-CSF
-mediated antiapoptotic effect on neutrophils, respectively, and both JNK isoforms are involved in TNF-alpha-induced and
GM-CSF
-induced superoxide release.
...
PMID:Distinct role of c-Jun N-terminal kinase isoforms in human neutrophil apoptosis regulated by tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor. 1843 1
Exposure of mice to hyperoxia induces alveolar epithelial cell (AEC) injury, acute lung injury and death. Overexpression of
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
) in the lung protects against these effects, although the mechanisms are not yet clear. Hyperoxia induces cellular injury via effects on mitochondrial integrity, associated with induction of proapoptotic members of the Bcl-2 family. We hypothesized that
GM-CSF
protects AEC through effects on mitochondrial integrity. MLE-12 cells (a murine type II cell line) and primary murine type II AEC were subjected to oxidative stress by exposure to 80% oxygen and by exposure to H(2)O(2). Exposure to H(2)O(2) induced cytochrome c release and decreased mitochondrial reductase activity in MLE-12 cells. Incubation with
GM-CSF
significantly attenuated these effects. Protection induced by
GM-CSF
was associated with Akt activation.
GM-CSF
treatment also resulted in increased expression of the antiapoptotic Bcl-2 family member,
Mcl-1
. Primary murine AEC were significantly more tolerant of oxidative stress than MLE-12 cells. In contrast to MLE-12 cells, primary AEC expressed significant
GM-CSF
at baseline and demonstrated constitutive activation of Akt and increased baseline expression of
Mcl-1
. Treatment with exogenous
GM-CSF
further increased Akt activation and
Mcl-1
expression in primary AEC. Conversely, suppression of AEC
GM-CSF
expression by use of
GM-CSF
-specific small interfering RNA resulted in decreased tolerance of oxidative stress, Furthermore, silencing of
Mcl-1
prevented
GM-CSF
-induced protection. We conclude that
GM-CSF
protects alveolar epithelial cells against oxidative stress-induced mitochondrial injury via the Akt pathway and its downstream components, including
Mcl-1
. Epithelial cell-derived
GM-CSF
may contribute to intrinsic defense mechanisms limiting lung injury.
...
PMID:GM-CSF provides autocrine protection for murine alveolar epithelial cells from oxidant-induced mitochondrial injury. 2214 71
<< Previous
1
2